Potential Roles for Probiotics in the Treatment of COVID-19 Patients and Prevention of Complications Associated with Increased Antibiotic Use
Open Access
- 9 April 2021
- journal article
- review article
- Published by MDPI AG in Antibiotics
- Vol. 10 (4), 408
- https://doi.org/10.3390/antibiotics10040408
Abstract
Medical care for patients hospitalized with COVID-19 is an evolving process. Most COVID-19 inpatients (58–95%) received empiric antibiotics to prevent the increased mortality due to ventilator-associated pneumonia and other secondary infections observed in COVID-19 patients. The expected consequences of increased antibiotic use include antibiotic-associated diarrhea (AAD) and Clostridioides difficile infections (CDI). We reviewed the literature (January 2020–March 2021) to explore strategies to reduce these consequences. Antimicrobial stewardship programs were effective in controlling antibiotic use during past influenza epidemics and have also been shown to reduce healthcare-associated rates of CDI. Another potential strategy is the use of specific strains of probiotics shown to be effective for the prevention of AAD and CDI prior to the pandemic. During 2020, there was a paucity of published trials using these two strategies in COVID-19 patients, but trials are currently ongoing. A multi-strain probiotic mixture was found to be effective in reducing COVID-19-associated diarrhea in one trial. These strategies are promising but need further evidence from trials in COVID-19 patients.Keywords
This publication has 70 references indexed in Scilit:
- Comparison of pediatric and adult antibiotic-associated diarrhea andClostridium difficileinfectionsWorld Journal of Gastroenterology, 2016
- Systematic review with meta-analysis: Lactobacillus rhamnosus GG in the prevention of antibiotic-associated diarrhoea in children and adultsAlimentary Pharmacology & Therapeutics, 2015
- Systematic review with meta‐analysis: Saccharomyces boulardii in the prevention of antibiotic‐associated diarrhoeaAlimentary Pharmacology & Therapeutics, 2015
- Probiotics for the Primary and Secondary Prevention of C. difficile Infections: A Meta-analysis and Systematic ReviewAntibiotics, 2015
- Clostridium difficile Infection Seasonality: Patterns across Hemispheres and Continents – A Systematic ReviewPLOS ONE, 2015
- Deciphering meta-analytic results: a mini-review of probiotics for the prevention of paediatric antibiotic-associated diarrhoea and Clostridium difficile infectionsBeneficial Microbes, 2015
- Burden of Clostridium difficile on the Healthcare SystemClinical Infectious Diseases, 2012
- Seasonal Variations in Clostridium difficile Infections Are Associated with Influenza and Respiratory Syncytial Virus Activity Independently of Antibiotic Prescriptions: a Time Series Analysis in Québec, CanadaAntimicrobial Agents and Chemotherapy, 2012
- A Time-Series Analysis of Clostridium difficile and Its Seasonal Association with InfluenzaInfection Control & Hospital Epidemiology, 2010
- Predominant Role of Bacterial Pneumonia as a Cause of Death in Pandemic Influenza: Implications for Pandemic Influenza PreparednessThe Journal of Infectious Diseases, 2008